ITGA9 and rhabdomyosarcoma: The previous results from our laboratory showed ITGA9 as a Notch pathway target and as an interesting player in the metastatic potential of rhabdomyosarcoma cells, whose inhibition by miR-7 and miR-234-5p exerted strong anti-oncogenic effects [13, 14].